p53 binding prevents phosphatase-mediated inactivation of diphosphorylated c-Jun N-terminal kinase

Pramod S Gowda1, Fuchun Zhou2, Linda V Chadwell3

  • 1Departments of Biochemistry and The University of Texas Health Science Center, San Antonio, Texas 78229.

Insights

p53 protein directly enhances c-Jun N-terminal kinase (JNK) activity, promoting apoptosis. This interaction, conserved across species, prevents JNK dephosphorylation, acting as a fail-safe mechanism for cellular stress response.

Area of Science:

  • Molecular Biology
  • Cellular Stress Response
  • Apoptosis Signaling Pathways

Background:

  • Sustained c-Jun N-terminal kinase (JNK) activation promotes apoptosis following genotoxic stress.
  • p53 (also known as tumor protein p53) plays a role in the JNK-dependent apoptotic response to genotoxic stress, but the mechanism is unclear.
  • Previous studies show diminished JNK activity in p53-deficient cells after UV irradiation.

Purpose of the Study:

  • To elucidate the mechanism by which p53 potentiates JNK activity in response to genotoxic stress.
  • To investigate the direct interaction between p53 and JNK.
  • To determine if this interaction is conserved across species and its functional implications.

Main Methods:

  • Direct stimulation assays of JNK activity by p53, independent of transcription.
  • Co-immunoprecipitation and in vitro binding assays to detect physical complex formation between p53 and diphosphorylated JNK ((DP)JNK).
  • Mapping of the p53 interaction domain with JNK and assessment of JNK inactivation by MAPK phosphatase (MKP)-5 in the presence of p53.

Main Results:

  • Both Drosophila and human p53 directly stimulate JNK activity without requiring p53-dependent gene transcription.
  • p53 orthologs physically complex with (DP)JNK both in vivo and in vitro, indicating evolutionary conservation.
  • Human p53 DNA-binding domain (p53(DBD)) binds to (DP)JNK, preventing its inactivation by MKP-5 and allowing JNK to phosphorylate c-Jun.

Conclusions:

  • Stress-induced p53 increases potentiate JNK activation by inhibiting its dephosphorylation by MKPs.
  • The physical interaction between p53 and JNK is evolutionarily conserved and functionally significant.
  • The simultaneous activation of p53 and JNK may serve as a critical 'fail-safe' mechanism to ensure apoptosis induction under genotoxic stress.

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
DNA Damage can Stall the Cell Cycle02:36

DNA Damage can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
DNA Damage Can Stall the Cell Cycle02:36

DNA Damage Can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Inhibition of CDK Activity02:34

Inhibition of CDK Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.